COMMUNIQUÉS West-GlobeNewswire

TRACON Pharmaceuticals Presents Updated Data from Phase 1b/2 Study of TRC105 and Votrient® in Patients with Soft Tissue Sarcoma Including Angiosarcoma

09/11/2017 - 14:00

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

Iovance Biotherapeutics Announces New LN-144 Phase 2 Clinical Data from Metastatic Melanoma Trial to be Presented at SITC Meeting

09/11/2017 - 14:00

SAN CARLOS, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

CASMED Reports Third-Quarter 2017 Financial Results

09/11/2017 - 14:00

Conference Call Begins Today at 10:00 a.m. Eastern Time BRANFORD, Conn., Nov. 09, 2017 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in non-invasive cerebral oximetry technology, today [...]

NY-ESO Data Presented at the Connective Tissue Oncology Society (CTOS) Annual Meeting Confirm Potential of Adaptimmune’s SPEAR T-Cell Therapy

09/11/2017 - 14:00

PHILADELPHIA and OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, released updated data from the ongoing pilot study of [...]

Albireo to Present at the Jefferies 2017 London Healthcare Conference

09/11/2017 - 14:00

BOSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]

iCAD Announces Positive Clinical Data on Xoft System for Non-Melanoma Skin Cancer Treatment Selected as “Best of ASTRO 2017”

09/11/2017 - 14:00

NASHUA, N.H. and MIAMI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD ), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that clinical [...]

Hooper Holmes Announces Third Quarter 2017 Financial Results

09/11/2017 - 14:00

OLATHE, Kan., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. (OTCQX:HPHW) today announced third quarter 2017 financial results. "Third quarter revenue represents a 44 percent improvement compared to the third [...]

Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017

09/11/2017 - 14:00

MENLO PARK, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ: CORI ) today announced that it will report financial results for the fourth quarter and fiscal year ended September 30, 2017 on [...]

Atara Biotherapeutics Announces Third Quarter 2017 Financial Results and Recent Highlights

09/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Inovio Pharmaceuticals to Participate In Upcoming Investment Conferences

09/11/2017 - 14:00

PLYMOUTH MEETING, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that the Company will participate in the following upcoming investment conferences: Stifel 2017 [...]

Golden Leaf Holdings Wins Big at Third Annual Oregon DOPE Cup

09/11/2017 - 14:00

PORTLAND, Ore., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Golden Leaf Holdings (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, celebrated last week as [...]

VBL Therapeutics to Present at the 22nd Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) on November 18

09/11/2017 - 14:00

TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results

09/11/2017 - 13:50

CONSHOHOCKEN, Penn., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL ) today announced its third quarter 2017 financial results and several clinical accomplishments that occurred during [...]

Repligen Reports Third Quarter 2017 Financial Results

09/11/2017 - 13:30

Record quarterly revenue of $36.6 million represents 48% year-over-year growth Year-to-date revenue of $99.6 million represents 26% year-over-year growth Spectrum contributes revenue of $7.6 million in first two months [...]

Xtant Medical Postpones Release of Third Quarter 2017 Financial Results

09/11/2017 - 13:30

BELGRADE, Mont., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, announced that it has postponed [...]

Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

09/11/2017 - 13:30

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a Fortress Biotech (NASDAQ: FBIO ) Company, today announced financial results and recent corporate highlights for the [...]

Merus to Present at the Jefferies London Healthcare Conference

09/11/2017 - 13:30

UTRECHT, The Netherlands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton [...]

Idera Pharmaceuticals Presents Positive Translational and Clinical Data Update from Ongoing IMO-2125 Development Program at the 2017 Society for Immunotherapy of Cancer Annual Meeting (SITC)

09/11/2017 - 13:30

- Available Translational Data Continue to Demonstrate Correlation between Proliferation and Clonal Expansion of T-Cells to Clinical Responses - - An additional 5th Unconfirmed RECIST v1.1 Response Observed in 10th [...]

Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance

09/11/2017 - 13:30

GENERAL HIGHLIGHTS CINCINNATI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ) today: reported fourth quarter and full-year fiscal 2017 net revenues of $49.7 million and $200.8 million, [...]